GSK plc has completed its previously announced acquisition of IDRx Inc., a Boston-based, clinical-stage biopharmaceutical ...
GSK (GSK) plc announced that it has completed the acquisition of IDRx, Inc., a Boston-based, clinical-stage biopharmaceutical company dedicated ...
GSK completes acquisition of Boston-based, clinical-stage biopharma company, IDRx, Inc.
The FTSE 250 business's stock jumped 4.7%, or 6.3p, to 141.8p as investors bet it could be next food delivery group to be ...
Evening Standard on MSN23h
FTSE 100 Live 24 February: Just Eat backs £3.4bn takeover, B&M profit downgrade as boss quitsTwo former FTSE 100 stocks were in the spotlight today after Just Eat Takeaway.com backed a £3.4 billion takeover and B&M ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback